To our knowledge, the only study that obtained lower IC50 values than ours (∼8 μM), done by Ohsaki et al. on lung cancer cell lines (Ohsaki et al., 1992), utilized synthetic analogues of MAG2 in a 4-day treatment, compared to our 6-h treatment. The gene discussed is RETREG2; the disease is lung cancer.